Clinical Trial Update: Darbepoetin Alfa Compared With Epoetin Alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial comparing darbepoetin alfa with epoetin alfa for treating anemia in patients undergoing chemotherapy for cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Leukemia
• Lymphoma
• Lymphoproliferative Disorder
• Multiple Myeloma and Plasma Cell Neoplasm

Drugs mentioned

• EPOETIN ALFA (EPOETIN ALFA)
• darbepoetin alfa (darbepoetin alfa)

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Anemia, Leukemia | Phase 3 | Status: COMPLETED